Merck & Co. Inc.

NYSE: MRK · Real-Time Price · USD
76.83
0.43 (0.56%)
At close: May 30, 2025, 3:59 PM
77.00
0.21%
After-hours: May 30, 2025, 05:51 PM EDT

Merck & Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Animal Health segment Revenue 5.88B 34.78B 36.04B 37.44B
Animal Health segment Revenue Growth -83.10% -3.50% -3.73% n/a
Pharmaceutical segment Revenue 57.4B n/a n/a n/a
Pharmaceutical segment Revenue Growth n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 30, 2023 Dec 30, 2022 Dec 30, 2021 Dec 30, 2020 Dec 30, 2019 Dec 30, 2018 Dec 30, 2017 Dec 30, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Asia Pacific Revenue 11.83B 3.23B 3.61B 2.41B 2.86B 2.94B 2.91B 4.34B 3.92B 6.49B 7.42B 7.89B 20.39B 20.5B 20.23B
Asia Pacific Revenue Growth +266.88% -10.76% +50.15% -15.96% -2.68% +1.17% -32.93% +10.69% -39.66% -12.52% -5.92% -61.31% -0.50% +1.33% n/a
Emea Revenue 14.04B 3.09B 2.58B 2.21B 2.27B 2.47B 2.42B 2.34B 2.15B 10.68B 13.17B 13.14B 12.99B 4.83B 13.5B
Emea Revenue Growth +354.99% +19.52% +17.04% -2.99% -7.90% +2.24% +3.25% +8.54% -79.82% -18.95% +0.26% +1.15% +168.67% -64.18% n/a
Latin America Revenue 3.46B n/a n/a n/a n/a n/a n/a n/a n/a 2.82B 3.15B 3.2B 5.1B n/a 3.77B
Latin America Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a -10.41% -1.62% -37.22% n/a n/a n/a
United States Revenue 32.28B n/a n/a n/a n/a n/a n/a n/a n/a 17.52B 17.07B 18.25B n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a +2.62% -6.44% n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 2.55B 3.3B 2.73B 2.74B 2.48B 2.8B 2.52B 2.7B 2.48B 2.69B 2.52B 2.51B 2.32B 2.83B 2.34B 2.28B 2.19B 3.08B 2.06B 2.08B 2.56B 2.89B 2.59B 2.71B 2.42B 2.64B 2.44B 2.51B 2.51B 2.58B 2.46B 2.5B 2.47B 2.59B 2.39B 2.46B 2.32B 2.62B 2.47B 2.62B 2.6B
Selling, General, and Administrative Revenue Growth -22.57% +20.69% -0.29% +10.31% -11.45% +11.31% -6.77% +9.00% -7.74% +6.63% +0.32% +8.14% -17.92% +21.15% +2.41% +4.30% -29.11% +49.76% -1.20% -18.40% -11.56% +11.59% -4.54% +11.84% -8.25% +8.19% -2.59% 0.00% -2.75% +4.88% -1.64% +1.13% -4.67% +8.36% -2.64% +6.04% -11.36% +5.78% -5.79% +0.88% n/a
Research and Development Revenue 3.62B 4.58B 5.86B 3.5B 3.99B 9.63B 3.31B 13.32B 4.28B 3.77B 4.4B 2.8B 2.58B 3.07B 2.44B 4.32B 2.41B 5.84B 3.35B 2.08B 2.21B 2.55B 3.2B 2.19B 1.93B 2.21B 2.07B 2.27B 3.2B 2.28B 4.41B 1.78B 1.83B 4.65B 1.66B 2.15B 1.66B 1.8B 1.5B 1.67B 1.74B
Research and Development Revenue Growth -21.01% -21.80% +67.49% -12.32% -58.53% +191.11% -75.17% +211.53% +13.27% -14.19% +57.22% +8.62% -16.04% +25.48% -43.42% +79.15% -58.68% +74.29% +60.62% -5.61% -13.30% -20.47% +46.37% +13.36% -12.78% +7.06% -9.06% -28.85% +40.11% -48.31% +147.64% -2.62% -60.64% +179.39% -22.64% +29.66% -7.73% +19.87% -10.18% -3.86% n/a